|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Trading securities (including $1,128 and $1,326 with related parties) | ||||||||||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Margin lending, brokerage and other receivables, net | ||||||||||||||||||||
| Loans issued (including $135,132 and $121,177 from related parties) | ||||||||||||||||||||
| Loans issued (including $25,157 and $21,321 to related parties) | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Insurance contract assets | ||||||||||||||||||||
| Other assets, net (including $40,641 and $40,119 with related parties) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Securities repurchase agreement obligations | ||||||||||||||||||||
| Customer liabilities | ||||||||||||||||||||
| Margin lending and trade payables | ||||||||||||||||||||
| Insurance contract liabilities | ||||||||||||||||||||
| Current income tax liability | ||||||||||||||||||||
| Debt securities issued | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Payable for acquisition (including $15,769 and $0 to related parties) | ||||||||||||||||||||
| Liability arising from continuing involvement | ||||||||||||||||||||
| Unsettled liability arising from a private placement | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Commitments and Contingent Liabilities (Note 24) | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock - $0.001 par value; 20,000,000 shares authorized, no shares issued or outstanding | ||||||||||||||||||||
| Common stock - $0.001 par value; 500,000,000 shares authorized; 61,428,760 shares issued and outstanding as of June 30, 2026, and 61,292,581 shares issued and outstanding as of March 31, 2026, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL FRHC SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
Loading...
